» Articles » PMID: 33710668

Neurotensin: A Novel Mediator of Ovulation?

Overview
Journal FASEB J
Specialties Biology
Physiology
Date 2021 Mar 12
PMID 33710668
Citations 9
Authors
Affiliations
Soon will be listed here.
Abstract

The midcycle luteinizing hormone (LH) surge initiates a cascade of events within the ovarian follicle which culminates in ovulation. Only mural granulosa cells and theca cells express large numbers of LH receptors, and LH-stimulated paracrine mediators communicate the ovulatory signal within the follicle. Recent reports identified the neuropeptide neurotensin (NTS) as a product of granulosa cells. Here, we demonstrate that granulosa cells were the primary site of NTS expression in macaque ovulatory follicles. Granulosa cell NTS mRNA and protein increased after human chorionic gonadotropin (hCG) administration, which substitutes for the LH surge. To identify ovulatory actions of NTS, a NTS-neutralizing antibody was injected into preovulatory macaque follicles. hCG administration immediately followed, and ovaries were removed 48 hours later to evaluate ovulatory events. Follicles injected with control IgG ovulated normally. In contrast, 75% of NTS antibody-injected follicles failed to ovulate, containing oocytes trapped within unruptured, hemorrhagic follicles. Serum progesterone was unchanged. Of the three NTS receptors, SORT1 was highly expressed in follicular granulosa, theca, and endothelial cells; NTSR1 and NTSR2 were expressed at lower levels. Excessive blood cells in NTS antibody-injected follicles indicated vascular anomalies, so the response of monkey ovarian endothelial cells to NTS was evaluated in vitro. NTS stimulated endothelial cell migration and capillary sprout formation, consistent with a role for NTS in vascular remodeling associated with ovulation. In summary, we identified NTS as a possible paracrine mediator of ovulation. Further investigation of the NTS synthesis/response pathway may lead to improved treatments for infertility and novel targets for contraception.

Citing Articles

Decreased neurotensin induces ovulatory dysfunction via the NTSR1/ERK/EGR1 axis in polycystic ovary syndrome.

Wang D, Zhang M, Wang W, Chu W, Zhai J, Sun Y Front Med. 2024; 19(1):149-169.

PMID: 39648233 DOI: 10.1007/s11684-024-1089-z.


New insights into the ovulatory process in the human ovary.

Jo M, Brannstrom M, Akins J, Curry Jr T Hum Reprod Update. 2024; 31(1):21-47.

PMID: 39331957 PMC: 11696709. DOI: 10.1093/humupd/dmae027.


Neurotensin modulates ovarian vascular permeability via adherens junctions.

Pearson A, Shrestha K, Curry Jr T, Duffy D FASEB J. 2024; 38(7):e23602.

PMID: 38581236 PMC: 11034770. DOI: 10.1096/fj.202302652RR.


Neurotensin induces sustainable activation of the ErbB-ERK1/2 pathway, which is required for developmental competence of oocytes in mice.

Okamoto A, Nakanishi T, Tonai S, Shimada M, Yamashita Y Reprod Med Biol. 2024; 23(1):e12571.

PMID: 38510925 PMC: 10951886. DOI: 10.1002/rmb2.12571.


NTS, NTSR1 and ERs in the Pituitary-Gonadal Axis of Cycling and Postnatal Female Rats after BPA Treatment.

Gonzalez-Gomez M, Reyes R, Damas-Hernandez M, Plasencia-Cruz X, Gonzalez-Marrero I, Alonso R Int J Mol Sci. 2023; 24(8).

PMID: 37108581 PMC: 10138486. DOI: 10.3390/ijms24087418.


References
1.
Fagerberg L, Hallstrom B, Oksvold P, Kampf C, Djureinovic D, Odeberg J . Analysis of the human tissue-specific expression by genome-wide integration of transcriptomics and antibody-based proteomics. Mol Cell Proteomics. 2013; 13(2):397-406. PMC: 3916642. DOI: 10.1074/mcp.M113.035600. View

2.
Richard F, Barroso S, Martinez J, Labbe-Jullie C, Kitabgi P . Agonism, inverse agonism, and neutral antagonism at the constitutively active human neurotensin receptor 2. Mol Pharmacol. 2001; 60(6):1392-8. DOI: 10.1124/mol.60.6.1392. View

3.
Elvin J, Yan C, Matzuk M . Growth differentiation factor-9 stimulates progesterone synthesis in granulosa cells via a prostaglandin E2/EP2 receptor pathway. Proc Natl Acad Sci U S A. 2000; 97(18):10288-93. PMC: 27877. DOI: 10.1073/pnas.180295197. View

4.
Choi Y, Wilson K, Hannon P, Rosewell K, Brannstrom M, Akin J . Coordinated Regulation Among Progesterone, Prostaglandins, and EGF-Like Factors in Human Ovulatory Follicles. J Clin Endocrinol Metab. 2017; 102(6):1971-1982. PMC: 5470773. DOI: 10.1210/jc.2016-3153. View

5.
Trau H, Brannstrom M, Curry Jr T, Duffy D . Prostaglandin E2 and vascular endothelial growth factor A mediate angiogenesis of human ovarian follicular endothelial cells. Hum Reprod. 2016; 31(2):436-44. PMC: 4716810. DOI: 10.1093/humrep/dev320. View